Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaDiagnostics was a biotechnology company specializing in the development of label-free screening technologies for drug discovery. The company's core innovation, the SoPRano platform, utilized Localized Surface Plasmon Resonance (LSPR) to enable high-throughput, label-free binding assays using standard microplate readers. This technology allowed researchers to study molecular interactions, such as protein-protein and protein-small molecule binding, without the need for specialized, expensive equipment or fluorescent labels. While the company was active in providing these assay kits and services to the pharmaceutical industry, it eventually ceased operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaDiagnostics.